Ancora Advisors’s Transmedics TMDX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$49.7K Hold
500
﹤0.01% 1143
2025
Q4
$60.8K Hold
500
﹤0.01% 1080
2025
Q3
$56.1K Hold
500
﹤0.01% 1005
2025
Q2
$67K Hold
500
﹤0.01% 959
2025
Q1
$33.6K Hold
500
﹤0.01% 1092
2024
Q4
$31.2K Hold
500
﹤0.01% 1124
2024
Q3
$78.5K Hold
500
﹤0.01% 881
2024
Q2
$75.3K Hold
500
﹤0.01% 860
2024
Q1
$37K Hold
500
﹤0.01% 1040
2023
Q4
$39.5K Hold
500
﹤0.01% 1001
2023
Q3
$27.4K Hold
500
﹤0.01% 1074
2023
Q2
$42K Hold
500
﹤0.01% 948
2023
Q1
$37.9K Buy
+500
New +$34.6K ﹤0.01% 975

Other funds holding TMDX

Ancora Advisors's TMDX Position: Q1 2026 in Review

Ancora Advisors held its Transmedics (TMDX) position steady in Q1 2026 at 500 shares worth $49.7K. The position accounts for ﹤0.01% of the portfolio, ranked #1143.

Ancora Advisors first reported a position in TMDX in Q1 2023 and has held it in 13 quarters since. The position peaked at $78.5K in Q3 2024. 414 funds tracked by Wall St. Rank hold TMDX as of Q1 2026.

  • Ancora Advisors held 500 shares of Transmedics worth $49.7K as of Q1 2026.
  • Ancora Advisors left its Transmedics share count unchanged in Q1 2026.
  • Transmedics made up ﹤0.01% of Ancora Advisors's portfolio in Q1 2026, its #1143 holding.
  • Ancora Advisors first reported a position in Transmedics in Q1 2023 and has held it in 13 quarters since.
  • Ancora Advisors's Transmedics position peaked at $78.5K in Q3 2024.
  • 414 funds tracked by Wall St. Rank held Transmedics as of Q1 2026.

Based on Ancora Advisors's 13F filing for Q1 2026, filed 15 May 2026.